SAM
Shell Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,265
| Closed | -$498K | – | 1367 |
|
|
2022
Q3 | $498K | Sell |
11,265
-2,951
| -21% | -$130K | 0.02% | 568 |
|
|
2022
Q2 | $526K | Buy |
14,216
+3,194
| +29% | +$118K | 0.02% | 689 |
|
|
2022
Q1 | $408K | Sell |
11,022
-1,629
| -13% | -$60.3K | 0.01% | 908 |
|
|
2021
Q4 | $385K | Buy |
12,651
+48
| +0.4% | +$1.46K | 0.01% | 1011 |
|
|
2021
Q3 | $423K | Sell |
12,603
-566
| -4% | -$19K | 0.01% | 939 |
|
|
2021
Q2 | $525K | Sell |
13,169
-32,964
| -71% | -$1.31M | 0.01% | 888 |
|
|
2021
Q1 | $2.07M | Buy |
46,133
+33,597
| +268% | +$1.51M | 0.04% | 346 |
|
|
2020
Q4 | $709K | Buy |
12,536
+3,217
| +35% | +$182K | 0.01% | 627 |
|
|
2020
Q3 | $442K | Hold |
9,319
| – | – | 0.01% | 734 |
|
|
2020
Q2 | $549K | Sell |
9,319
-4,476
| -32% | -$264K | 0.01% | 619 |
|
|
2020
Q1 | $652K | Sell |
13,795
-127
| -0.9% | -$6K | 0.02% | 560 |
|
|
2019
Q4 | $841K | Sell |
13,922
-2,924
| -17% | -$177K | 0.02% | 622 |
|
|
2019
Q3 | $1.01M | Sell |
16,846
-74
| -0.4% | -$4.43K | 0.02% | 529 |
|
|
2019
Q2 | $1.09M | Buy |
16,920
+2,808
| +20% | +$180K | 0.02% | 518 |
|
|
2019
Q1 | $1.15M | Hold |
14,112
| – | – | 0.03% | 504 |
|
|
2018
Q4 | $763K | Sell |
14,112
-1,200
| -8% | -$64.9K | 0.02% | 634 |
|
|
2018
Q3 | $790K | Hold |
15,312
| – | – | 0.02% | 798 |
|
|
2018
Q2 | $638K | Sell |
15,312
-819
| -5% | -$34.1K | 0.01% | 866 |
|
|
2018
Q1 | $711K | Buy |
+16,131
| New | +$711K | 0.01% | 805 |
|
|
2016
Q4 | – | Sell |
-2,296
| Closed | -$84K | – | 1078 |
|
|
2016
Q3 | $84K | Sell |
2,296
-3,219
| -58% | -$118K | ﹤0.01% | 1007 |
|
|
2016
Q2 | $128K | Sell |
5,515
-618
| -10% | -$14.3K | ﹤0.01% | 857 |
|
|
2016
Q1 | $248K | Hold |
6,133
| – | – | 0.01% | 806 |
|
|
2015
Q4 | $380K | Buy |
+6,133
| New | +$380K | 0.01% | 746 |
|
|
2015
Q3 | – | Sell |
-11,223
| Closed | -$646K | – | 875 |
|
|
2015
Q2 | $646K | Buy |
11,223
+334
| +3% | +$19.2K | 0.01% | 708 |
|
|
2015
Q1 | $693K | Buy |
+10,889
| New | +$693K | 0.01% | 724 |
|